Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP345180.RAETahFbQM76lfW0sZOmCVYroRFKv2N22fLRoVZXoSn9g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP345180.RAETahFbQM76lfW0sZOmCVYroRFKv2N22fLRoVZXoSn9g130_assertion type Assertion NP345180.RAETahFbQM76lfW0sZOmCVYroRFKv2N22fLRoVZXoSn9g130_head.
- NP345180.RAETahFbQM76lfW0sZOmCVYroRFKv2N22fLRoVZXoSn9g130_assertion description "[Therefore, the SEA D227A-Mx3 diabody is considered to be a promising reagent in specific targeted immunotherapy for BDC and other MUC1-positive carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP345180.RAETahFbQM76lfW0sZOmCVYroRFKv2N22fLRoVZXoSn9g130_provenance.
- NP345180.RAETahFbQM76lfW0sZOmCVYroRFKv2N22fLRoVZXoSn9g130_assertion evidence source_evidence_literature NP345180.RAETahFbQM76lfW0sZOmCVYroRFKv2N22fLRoVZXoSn9g130_provenance.
- NP345180.RAETahFbQM76lfW0sZOmCVYroRFKv2N22fLRoVZXoSn9g130_assertion SIO_000772 11845258 NP345180.RAETahFbQM76lfW0sZOmCVYroRFKv2N22fLRoVZXoSn9g130_provenance.
- NP345180.RAETahFbQM76lfW0sZOmCVYroRFKv2N22fLRoVZXoSn9g130_assertion wasDerivedFrom befree-2016 NP345180.RAETahFbQM76lfW0sZOmCVYroRFKv2N22fLRoVZXoSn9g130_provenance.
- NP345180.RAETahFbQM76lfW0sZOmCVYroRFKv2N22fLRoVZXoSn9g130_assertion wasGeneratedBy ECO_0000203 NP345180.RAETahFbQM76lfW0sZOmCVYroRFKv2N22fLRoVZXoSn9g130_provenance.